This two-day event provides updates on global and domestic regulatory updates, policy issues and discusses various payment models and payment pathways for medical devices, diagnostics, drug delivery, and digital health products.
The agenda includes keynotes from elected officials and guest speakers from the FDA and CMS, and comprehensive presentations from industry representatives, provider, hospital and payor partners, and regulatory, reimbursement and policy experts.
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.